Please login to the form below
COVID-19 testing
This page shows the latest COVID-19 testing news and features for those working in and with pharma, biotech and healthcare.
Oxford University, Prenetics to advance COVID-19 rapid testing for other infectious diseases
Rapid testing technology at the core of the collaboration is used in Oxford University's COVID-19 test. ... The new collaboration follows Prenetics’ acquisition of Oxford University spinout COVID-19 testing company Oxsed last year.
Latest news
-
GSK and Medicago initiate late-stage COVID-19 vaccine study
GlaxoSmithKline (GSK) and Medicago have started phase 3 clinical testing of their plant-based adjuvanted COVID-19 vaccine. ... This advance to late stage clinical testing further reinforces our confidence in the adjuvanted vaccine candidate's potential
-
Roche buys GenMark for $1.8bn to bolster diagnostics portfolio
Swiss pharma company will gain respiratory pathogen panels to strengthen its COVID-19 testing capabilities. ... This diagnostic identifies the most common viral and bacterial organisms associated with upper respiratory infection, including SARS-CoV-2,
-
Verily and Janssen to collaborate on home-based COVID-19 immune response study
Researchers will collect biological measurements, clinical and epidemiological data at the time of COVID-19 testing. ... Verily is also conducting another programme – the Baseline COVID-19 testing programme – to advance and expand testing and
-
GSK and CureVac look to develop next-generation mRNA COVID-19 vaccines
programme. CureVac is already testing a first-generation mRNA COVID-19 vaccine – CVnCoV – currently in late-stage clinical development. ... The GSK/CureVac deal will focus on developing a novel mRNA-based COVID-19 vaccine candidate, by using
-
Cambridge University develops DNA test for secondary infections in COVID-19 patients
Patients with the most severe forms of COVID-19 can often required mechanical ventilation to remain alive. ... Using this test, we found that patients with COVID-19 were twice as likely to develop secondary pneumonia as other patients in the same
GSK and Medicago initiate late-stage COVID-19 vaccine study
Roche buys GenMark for $1.8bn to bolster diagnostics portfolio
Verily and Janssen to collaborate on home-based COVID-19 immune response study
Cambridge University develops DNA test for secondary infections in COVID-19 patients
More from news
Approximately 1 fully matching, plus 31 partially matching documents found.
Latest Intelligence
-
Pharma’s authentic proof of purpose influences decisions among HCPs and payers
By Ludivine Delattre and Stacy Vaughn. The COVID-19 pandemic has been testing the fragility of global and national healthcare delivery systems to their breaking points.
-
The power of remote personal interactions: COVID-19 pandemic and the increasing role of remote engagement
when/the extent to which countries were most significantly impacted by COVID-19. ... Although some level of face-to-face interaction is returning, this interaction:. is likely to come with additional requirements for company representatives for COVID-19
-
As COVID-19 takes over the world, biopharma fights back
Encouraged by this initial data, Sanofi and Rengeneron decided to take their own IL-6 inhibitor, Kevzara (sarilumab), into clinical testing for COVID-19. ... patients with COVID-19, as appropriate, when a clinical trial is not available or feasible”.
Pharma’s authentic proof of purpose influences decisions among HCPs and payers
The power of remote personal interactions: COVID-19 pandemic and the increasing role of remote engagement
As COVID-19 takes over the world, biopharma fights back
More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.
Latest from PMHub
-
Blockchain in Healthcare: Predictions for the Post-COVID World
Dr. Jody Ranck, EVP, Global Strategy at Ram Global, discusses the novel ThEA diagnostic platform for rapid COVID-19 testing.
-
Advancing Precision Medicine in Oncology
He also dives into the promises and pitfalls of genomic testing and precision medicine in oncology, and gives his take on how to build authentic relationships with oncology KOLs during and ... after COVID-19.
-
Social listening report: Is COVID-19 impacting clinical trial recruitment?
Outside of COVID-19 research, clinical trials are being impacted regardless of indication. ... COVID-19 testing is not part of trial protocols and patients may need to be removed from study populations for safety reasons.
Social listening report: Is COVID-19 impacting clinical trial recruitment?
More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
-
Digital account director
-
Competitive
- Account Manager - Healthcare Consultancy
-
Salary depending on experience
- Principal/ Senior/ Medical Writer – Global Med Ed and Comms Agen...
-
Highly competitive salary
- Project Director, Healthcare Marketing Agency patient focus Lond...
-
Highly competitive salary
- Senior Consultant, Pricing & Market Access Consultancy, circ...
-
circa £100K package
-
Events Executive
-
Depending on Experience
- Digital Project Director, Healthcare Marketing Agency patient fo...
-
Highly competitive salary
- One dose of AZ’s COVID-19 vaccine ‘highly effective’ against severe disease from variants
- The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
- Mixing AZ and Pfizer COVID-19 vaccines increases antibody levels
- CHMP rejects Kyowa Kirin’s Parkinson’s disease drug
- Novavax announces further delays for regulatory filings of COVID-19 vaccine
- Google’s DeepMind opens ‘breakthrough’ protein database to the world
- Merck & Co’s sales bounce back in ‘ongoing recovery from COVID-19’
- Lilly and Kumquat Biosciences link up in $2bn-plus immuno-oncology deal
- Michael J. Fox Foundation and IBM reveal new AI model for Parkinson’s disease
- BMS’ Q2 results beat expectations with strong performance across core therapy areas
- Amanda Pritchard becomes NHS England’s first female chief executive
- Understanding the ‘real world’ starts and ends with the patient
- One dose of AZ’s COVID-19 vaccine ‘highly effective’ against severe disease from variants
- Michael J. Fox Foundation and IBM reveal new AI model for Parkinson’s disease
- Roche engaged in talks with FDA for Alzheimer’s drug candidate
- Pharma’s authentic proof of purpose influences decisions among HCPs and payers
- Merck & Co's cancer drug Keytruda gaining traction in US
- Tyson Fury takes on his Invisible Opponent in hard hitting ad for suicide prevention charity Campaign Against Living Miserably
PMHub
Page & Page and Partners
For those who can imagine better, Page & Page and Partners (P&P) is home to meaningful encounters of a marketing, communication...
Latest intelligence
- Top 10 ways to leverage the Impetus InSite Platform® to (virtually) launch your brand
- The Impetus InSite Platform® can be used to facilitate virtual and hybrid engagement at all stages of the product lifecycle. Here, we share 10 of the most popular ways to...
- Employee wellbeing in creative agencies: three tips to get you started
- Paul Hutchings, founder of fox&cat, and new friend, Welfy, a workplace wellbeing training firm, discuss the importance of collaboration...
- Managing unhelpful pressure in your creative agency: the human approach
- Paul Hutchings, founder of fox&cat, answers the questions: what does it mean to be human in 2021? Are we putting ourselves under too much pressure?...
